Skip to main content

Table 3 Radiologic response of GMB patients following Macdonald et al.[17]

From: MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

 

Radiologic response

MGMT

Negative

Positive

Unmethylated

33 (82.5%)

7 (17.5%)

Methylated

17 (56.7%)

13 (43.3%)

Total

50 (71.4%)

20 (28.6%)

  1. The methylation of MGMT showed a significant correlation with radiologic response (p < 0.05).